Clinical trial Recruiting at 3 sites Phase 1 Interventional Ages 18 and up

Remote monitoring for adults with depression using ThIA Suivi

Official title: Evaluation of the Clinical Efficacy of a New Strategy for Managing Patients With Depression Using an Innovative Remote Medical Monitoring System

Run by ThIA Santé Mentale · NCT07878754 · Data updated 2026-11-12

This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.

More Depression Chronic trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment608 (estimated)
SponsorThIA Santé Mentale
Industry-sponsored
Locations3 sites (Bron and 2 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT07878754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a PHQ-9 score of 15 or higher and a confirmed depression diagnosis, under the care of the investigator, with internet access and able to participate in a French-language protocol.

Probably not a fit

Persons without access to or ability to use the digital monitoring tool, or without sustained engagement in remote monitoring, may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional phase 1 trial evaluates ThIA Suivi, a digital remote-monitoring device, in adults with diagnosed depression. Participants continue their regular psychiatric care while either using the ThIA Suivi tool or receiving usual care. The primary outcome is the share of patients with a clinically meaningful improvement in depression symptoms, defined as a 5-point or greater reduction on the PHQ-9 after 3 months. Questionnaires track symptom changes over time, and safety and adherence are monitored. The study is conducted under real-world clinical supervision at multiple French centers.

Why it matters

Potential benefit: If successful, patients could experience greater symptom improvement through enhanced, continuous monitoring and timely interventions.

How similar studies have gone: Prior similar digital-mental-health monitoring approaches have shown potential benefits in symptom management, but results vary by setting and population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a PHQ-9 score of ≥ 15 and a confirmed diagnosis of depression
* Patients under the care of the investigator;
* Patients who have not received any treatment for at least 6 weeks and to whom the investigator prescribes an antidepressant.
* Patients with a smartphone, computer or tablet with internet access;
* Patients covered by a health insurance scheme;
* Patients able to read and understand French;
* Patients who have signed a written, informed consent form in person to take part in the study.

Exclusion Criteria:

* Patients under guardianship, curatorship or judicial protection, or subject to any other administrative or judicial measure resulting in the deprivation of rights and freedoms;
* Patients with neurocognitive disorders or psychiatric conditions (e.g. psychotic disorders, cognitive impairments or manic states) that may compromise their ability to give free and informed consent and/or to comply with the study protocol;
* Patients at imminent risk of suicide or with severe depression accompanied by psychotic symptoms;
* Patients deemed non-autonomous by the psychiatrist, i.e. those who, according to clinical assessment, are unable to manage their daily activities independently or lack sound judgement;
* Patients already enrolled in another interventional study
* Vulnerable persons as defined in Articles L. 1121-5 to 8 and L. 1122-1-2 of the French Public Health Code are excluded from the study.

Where it's running

  • Centre Hospitalier Le Vinatier
    Bron, France
    Recruiting
  • Hôpital Novo
    Pontoise, France
    Recruiting
  • Hôpital Uzès - Le Mas Careiron Secteur 30G07 - CMP de Saint Hippolyte du Fort
    Uzès, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.